Loughlin K R
Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Contemp Urol. 1996 Jan;8(1):56-61, 64, 67-8.
Management of benign prostatic hypertrophy has been and continues to be a major focus of urologic care. Every year, some 300,000 transurethral resections are performed annually in the United States. In this Point and Counterpoint, Drs. Madsen, Bruskewitz, and Kabalin review the relative merits of transurethral incision and laser prostatectomy, two newer treatments for BPH.
良性前列腺增生的管理一直是且仍将是泌尿外科护理的主要重点。在美国,每年大约进行30万例经尿道前列腺切除术。在本期“正方与反方”栏目中,马德森博士、布鲁斯凯维茨博士和卡巴林博士回顾了经尿道前列腺切开术和激光前列腺切除术这两种治疗良性前列腺增生的较新疗法的相对优点。